Sinopharm

All news and posts of our editorial team on the topic

Report: Delayed approval of BioNTech
Apparently, China wants to give preference to a self-developed mRNA vaccine instead of approving the German product from BioNTech. The Wall Street Journal quotes informed circles as saying that the approval procedure for the BioNTech preparation is currently deliberately delayed. The reason is concern about confidence in homegrown vaccines. Accelerated approval of the state-of-the-art ingredient […] continue reading →
Bangladesh produces Sinopharm vaccine
Sinopharm’s Chinese Covid vaccine will soon begin production in Bangladesh. As the Chinese news agency Xinhua reports, a declaration to this effect was already signed in Beijing and Dhaka on Monday during an online conference. According to the statement, pharmaceutical company Incepta will manufacture the Chinese vaccine in Bangladesh’s capital. According to the plan, a […] continue reading →
EU vaccine passport leaves choice of Chinese vaccine open
The European Union’s planned digital vaccination passport currently excludes Chinese vaccines from Sinopharm and Sinovac, but the EU is giving member states the freedom to decide whether to accept COVID-19 vaccines, which have not yet been approved by the European Medicines Agency (EMA). The EU Commission had unveiled the digital vaccination certificate, called “Digital Green […] continue reading →